Search
Bisoctrizole
go.drugbank.com/drugs/DB11262ApprovedBisoctrizole is not approved by the FDA, but is approved in the EU and other parts of the world as a UV-filter in sunscreens, day care products and skin lightening products at a maximum concentration of … Bisoctrizole, or methylene bis-benzotriazolyl tetramethylbutylphenol, is a broad-spectrum organic UV filter that is marketed as Tinosorb M [A19212].
Eniluracil
go.drugbank.com/drugs/DB03516InvestigationalEniluracil, which was previously under development by GlaxoSmithKline (GSK), is being developed by Adherex to enhance the therapeutic value and effectiveness of 5-fluorouracil (5-FU), one of the world’ … Eniluracil could improve 5-FU by increasing its effectiveness, reducing its side effects and/or making it orally available.
Ritodrine
go.drugbank.com/drugs/DB00867ApprovedWithdrawnAdrenergic beta-agonist used to control premature labor.
Methoxsalen
go.drugbank.com/drugs/DB00553ApprovedInvestigationalA naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA adducts in the presence of ultraviolet A irradiation.
Synonyms: O-methylxanthotoxolCategories: Antipsoriatics for Systemic Use, Antipsoriatics for Topical UseAZD-8165
go.drugbank.com/drugs/DB15132InvestigationalAZD-8165 is under investigation in clinical trial NCT01150812 (Oral AZD8165 After Single Oral Ascending Doses in Healthy Male Subjects).
Ferric chloride
go.drugbank.com/drugs/DB15536ApprovedMixtures: Addaven Concentrate for Solution for Infusion, ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSIONMestranol
go.drugbank.com/drugs/DB01357ApprovedWithdrawnIt must be demethylated to be biologically active. It is used as the estrogen component of many combination ORAL contraceptives.
Categories: Hormonal Contraceptives for Systemic UseCataract development
go.drugbank.com/conditions/DBCOND0096028Synonyms: Cataract form (observable entity)H3B-8800
go.drugbank.com/drugs/DB14017InvestigationalH3B-8800 was granted orphan drug status by the FDA in August 2017 and is in clinical trials for the treatment of acute myelogenous leukemia and chronic myelomonocytic leukemia [L2551]. … H3B-8800 is a novel spliceosome inhibitor developed by H3 Biomedicine [L2551].
Galidesivir
go.drugbank.com/drugs/DB11676Investigational[L12039,L12084] Phase 1 clinical trials have begun to determine the safety of this drug in humans. … Galidesivir is an adenosine analogue that has been investigated for use against Zaire Ebolavirus.
Categories: Experimental Unapproved Treatments for COVID-19